Intel and the Michael J. Fox foundation for Parkinson’s Research have teamed up, aiming to track and monitor those affected by the disease with wearable tech.
By aggregating data from large groups of people, researchers will be able to monitor patterns and pick up symptoms in a bid to help find a cure.
A new app will let patients record how they’re feeling, as well as log any medication they are taking, allowing researchers to monitor the results unobtrusively.
Intel has developed a big data analytics platform for wearables that integrates a number of software components including Cloudera, which collects, stores and manages data.
The platform is deployed on a cloud infrastructure, which processes and detects changes in the data, allowing researchers to identify changes and measure the progression of the disease.
Todd Sherer, PhD, CEO of The Michael J. Fox Foundation, said: “Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.”
Diane Bryant, senior vice president and general manager of Intel’s Data Center Group, added: “Emerging technologies can not only create a new paradigm for measurement of Parkinson’s, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research.”